KRROKorro Bio Inc.
KRRO
Korro Bio Inc.2,639
Mkt Cap
$308.02MVolume
3.54M52W High
$57.9452W Low
$10.29PE Ratio
-3.22KRRO Fundamentals
Price
$7.57Prev Close
$32.80Open
$33.0950D MA
$38.69Beta
0.75Avg. Volume
240,989.39EPS (Annual)
-$9.37P/B
2.56Rev/Employee
$21,836.54Korro Bio Stock Crashes Over 75% After-Hours On Drug Failure, Downgrades And Layoffs — Yet Retail Flags ‘Buy-The-Fear’ Setup
Clear Street cut its price target to $7 from $93, saying KRRO-110 failed to reach protective protein levels in its Phase 1/2 study for Alpha-1 Antitrypsin Deficiency.
Korro Bio, Inc. (KRRO) Reports Q3 Loss, Lags Revenue Estimates
Korro Bio, Inc. (KRRO) delivered earnings and revenue surprises of +26.44% and -27.33%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5h ago
Korro Bio Board Changes and Strategic Advisor Agreement
An announcement from Korro Bio (KRRO) is now available. David L. Lucchino resigned from our Board of Directors on August 26, 2024, but will stay co...
TipRanks Financial Blog·1y ago
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
William Blair initiates coverage on Korro Bio highlighting its innovative RNA editing platform, ADAR-based OPERA. The analyst rates the stock Outperform, noting its potential in treating alpha-1...
Benzinga·1y ago
Korro to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Chief Executive Officer and President, Ram Aiyar, Ph.D., Chief Financial Officer...
Globe Newswire·2y ago
Piper Sandler Reiterates Overweight Rating for Korro Bio (NASDAQ:KRRO)
Piper Sandler restated their overweight rating on shares of Korro Bio (NASDAQ:KRRO - Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Piper Sandler currently has a...
Ticker Report·2y ago
We Think Korro Bio (NASDAQ:KRRO) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Simply Wall St·2y ago
Korro Bio (NASDAQ:KRRO) Price Target Increased to $115.00 by Analysts at HC Wainwright
Korro Bio (NASDAQ:KRRO Free Report) had its price target lifted by HC Wainwright from $100.00 to $115.00 in a research note published on Thursday, Marketbeat Ratings reports. The firm...
Zolmax·2y ago
Korro Bio (NASDAQ:KRRO) Rating Reiterated by Piper Sandler
Korro Bio (NASDAQ:KRRO Get Free Report)s stock had its overweight rating restated by equities research analysts at Piper Sandler in a report issued on Wednesday, Benzinga...
Zolmax·2y ago